# Bionime Corporation: Not applicable (device, behavioral) study in Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2 (104 participants)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | Bionime Corporation |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study |
| NCT ID | NCT07889388 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Diabetes Mellitus, Type 1 Diabetes; Diabetes Mellitus, Type 2; Diabetes, Gestational |
| Intervention types | device |
| Target enrollment | 104 |
| Site countries | Germany |
| Posted | 2026-10-22 |
| Planned start | 2026-06-09 |
| Event | Newly registered study |
| Event date | 2026-10-22 |

## Why this score
- Industry sponsor (buys outsourced services).
- 104 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07889388). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.